Proto Labs, Inc. (PRLB) Hammered 4.24%: Factors To Watch On June, 15

Proto Labs, Inc. (NYSE:PRLB) is a big mover this session as the company shares are trading 4.24% or 4.54 points lower from last closing price of $106.99, reaching $102.45 at last check. So what’s going on with PRLB shares anyway? The price has dropped in 2 of the last 5 days and is up 1.25% over the past week. It will be exciting to see whether the stock manages to continue decreasing or take a minor break for the next few days. The move came on weak volume too with far less shares changing hands than in a normal session. Trading activity as of this writing weakened by -12,821 shares, and in total 131279 shares valued at $13.45 million were seen changing hands compared with 144100 shares valued at $15.417 million recorded at the previous session. You should take into consideration that a falling volume on lower prices shows the bearish trend but this is an early indication which means that the PRLB stock is near its bottom.

Proto Labs, Inc. (PRLB) shares have notched a 3-month gain of about 1.25%, but has still tumbled -5.14% year to date. By comparison, the stock sank -18.95% over the past 12 months, while it jumped 0.86% over the 1 month. The company’s market cap is around $2.83B, with its short interest ratio standing at 8.63%.

In the current trading session for PRLB, the stock witnessed two major price actions, it rose to a high of $106.97 and was down as much as $102.45 at one point. The high recorded is very low when compared to their 52-week high which is $94.2. The 52-week high is now at -38.22 distance from current price. Their recent low of $166.6 represents a 9.26% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for PRLB is $119.25, this is below the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.

The stock of Proto Labs, Inc. earned $2.88 per share in the trailing 12 months and has a P/E ratio of 35.57. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is higher than the ones recorded by the industry which is 24.82 and higher compared to the sector’s average of 24.02. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. PRLB also has P/S multiple of 6. This is greater versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 4.27x.

The company recorded an interesting insider sale transaction by the CFO on Sep 24, 2018. A Securities and Exchanges Commission filings show that John Way sold a total of 8,000 PRLB shares that day for a sum of around $1,272,800. The filings show that the insider now retains 30,503 shares, currently worth $3,125,032. Proto Labs, Inc. (PRLB) insiders have acquired 7,866 shares in the stock within the past three months. The total insider sales reported to the SEC in that time frame amounted to 252 shares. In total, individual insiders traded 8,118 shares in the business, which makes up 13.105% of 61,945 shares that were traded over a year. In the past 12 months, insiders have purchased 28,299 shares while the seller parted with 33,646 shares.

PRLB‘s last price was down -14.22% as compared to the average trading price of 50 days recorded at $119.43 while enlarging the period to 200 trading days, the average closing price was $107.2. At present, there are 26.44 million in the total number of common shares owned by the public and among those 25.42 million shares have been available to trade. The percentage of shares being held by the company management was 0.8% while institutions stake was 93.9%. The company has generated positive returns on equity over the last 12 months (14%). It managed to keep its gross profit margin at 53.1% over the past 12 months.

When assessing the full upside of the PRLB stock, there is another set of technicals that should be looked into and considered. Its -0.73% decline from moving average of $103.2 has brought about a negative sentiment when calculated over the last 20 days. The market has allocated a beta of 1.51 to the stock. With the beta been greater than one, this implies that the company shares are theoretically more volatile than the market, something that the traders definitely are keeping an eye on.

Most of the analysts surveyed by Thomson/First Call think quite highly of Proto Labs, Inc. — 2 analysts rate the stock as a buy with another 0 rating it strong buy. There are 1 analysts who maintain a hold rating for the stock, with 0 giving it a sell rating. Analysts arrived at a 12-month price target of $134 on shares of Proto Labs, Inc. (NYSE:PRLB), which corresponds to 30.67% upside potential than its current market price of $102.45 and implies potential despite the recent drop in the price. However, their current target price has fallen from $134 a month ago and is down handily from the consensus target of $134 a quarter ago.

In the last five years, the EPS of the company has been roughly 15.6%. Though the percentage looks encouraging, extra tailwinds are emerging as looking out over a next 5-year period, with analysts estimating that their earnings will increase annually by 19.6%. The revenue of the company has risen at an average annualized rate of about 22.3 over the last five years. The company recently recorded an increase of 5.4%, but this figure is rather unattractive.

Let’s briefly check the hedge fund interest towards PRLB stock. Metropolitan Life Insurance Co NY trimmed position in the company after it dumped -1.8% or 8,855 shares of its common stock. The hedge fund now owns 8,696 shares worth $890,905, SEC documents show. Slow Capital Inc. cut assets in the stock as 4824.13 shares have been sold, reducing its stake by -2.2% to 4,718 shares which are currently valued at $483,359. In addition, FMR LLC recently reported that it now owns 683 shares making a total of $69,973 based on the recent price. This refelects a change of -17.6% in their ownership.